Ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma: CARTITUDE‐1 (phase 2) Japanese cohort

Chimeric antigen receptor (CAR) T cells targeting B‐cell maturation antigen have shown positive responses in patients with multiple myeloma (MM). The phase 2 portion of the CARTITUDE‐1 study of ciltacabtagene autoleucel (cilta‐cel) included a cohort of Japanese patients with relapsed/refractory MM....

Descripción completa

Detalles Bibliográficos
Autores principales: Ri, Masaki, Suzuki, Kenshi, Ishida, Tadao, Kuroda, Junya, Tsukamoto, Taku, Teshima, Takanori, Goto, Hideki, Jackson, Carolyn C., Sun, Huabin, Pacaud, Lida, Fujikawa, Ei, Yeh, Tzu‐Min, Hatayama, Tomoyoshi, Aida, Kensuke, Sunagawa, Yoshihiro, Iida, Shinsuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746030/
https://www.ncbi.nlm.nih.gov/pubmed/36052883
http://dx.doi.org/10.1111/cas.15556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746030/
https://www.ncbi.nlm.nih.gov/pubmed/36052883
http://dx.doi.org/10.1111/cas.15556

Ejemplares similares